FIRST AID STEP 2 PATHOMA

7.1 Vasculitis, 27 min.

7.2 Hypertension (HTN), 7 min.
7.3 Arteriosclerosis, 18 min.
7.4 Aortic Dissection and Aneurysm, 13 min.
7.5 Vascular Tumors, 5 min.
Cardiovascular, pp.
8.1 Ischemic Heart Disease (IHD), 30 min.
17 - 48
8.2 Congestive Heart Failure (CHF), 6 min.
8.3 Congenital Defects, 17 min.
8.4 Valvular Disorders, 25 min.
8.5 Endocarditis, 7 min.
8.6 Cardiomyopathy, 8.7 Cardiac Tumors, 8 min.

19.1 Inflammatory Dermatoses, 15 min.

Dermatology, pp. 49 19.2 Blistering Dermatoses, 9 min.
- 81 19.3 Epithelial Tumors, 8 min.
19.4 Disorders of Pigmentation and Melanocytes, 12 min.

15.1 Anterior Pituitary Gland, 15.2 Posterior Pituitary Gland,

14 min.
15.3 Thyroid Gland, 15.4 Hyperthyroidism, 15.5
Endocrinology, pp. Hypothyroidism, 15.6 Thyroiditis, 15.7 Thyroid Neoplasia,
83 - 110 26 min.
15.8 Parathyroid Gland, 11 min.
15.9 Endocrine Pancreas, 15 min.
15.10 Adrenal Cortex, 15.11 Adrenal Medulla, 25 min.
Epidemiology, pp.
111 - 124
Ethics and Legal
Issues, pp. 125 - 130
 10.1 Oral Cavity, 6 min.
10.2 Salivary Gland, 7 min.
10.3 Esophagus, 28 min.
10.4 Stomach, 35 min.
10.5 Small Bowel, 31 min.
10.6 Appendix, 10.7 Inflammatory Bowel Disease, 19 min.
Gastrointestinal,
10.8 Colon (1), 22 min.
pp. 131 - 166
10.8 Colorectal Carcinoma (2), 9 min.
11.1 Exocrine Pancreas, 13 min.
11.2 Gallbladder and Biliary Tract, 11 min. 11.3 Liver:
Jaundice, 12 min.
11.3 Liver: Hepatitis, 8 min.
11.3 Liver: Cirrhosis & Tumors, 21 min.

4.1 Primary Hemostasis and Related Bleeding Disorders, 43

min.
4.2 Secondary Hemostasis and Related Disorders, 21 min.
4.3 Other Disorders of Hemostasis, 13 min.
4.4 Thrombosis, 22 min.
4.5 Embolism, 12 min.
5.1 Anemia, 7 min.
5.2 Microcytic Anemias Part 1, 28 min.
5.2 Microcytic Anemias Part 2, 19 min.
5.2 Microcytic Anemias Part 3, 19 min.
5.3 Macrocytic Anemia, 22 min.
5.4 Normocytic Anemia, 15 min.
Hematology/Oncolo
5.5 Normocytic Anemias w/ Extravascular Hemolysis, 26
gy, pp. 167 - 194
min.
5.6 Normocytic Anemias w/ Intravascular Hemolysis, 5.7
Anemia Due to Underproduction, 27 min.
6.1 Leukopenia and Leukocytosis, 21 min. 6.2 Acute
Leukemia, 19 min.
6.3 Chronic Leukemia, 11 min.
6.4 Myeloproliferative Disorders (MPD), 22 min.
6.5 Lymphadenopathy (LAD), 6.6 Lymphoma, 6.7 Hodgkin
Lymphoma (HL), 31 min.
6.8 Plasma Cell Disorders (Dyscrasias), 6.9 Langerhans Cell
Histiocytosis, 15 min.

Infectious Disease,
pp. 195 - 234
 18.1 Skeletal System, 25 min.
18.2 Bone Tumors, 15 min.
Musculoskeletal,
18.3 Joint, 21 min.
pp. 235 - 255
18.4 Skeletal Muscle, 18.5 Neuromuscular Junction, 18.6
Soft Tissue Tumors, 16 min.

17.1 Developmental Anomalies, 5 min.

17.2 Spinal Cord Lesions, 9 min.
17.3 Meningitis, 6 min.
Neurology, pp. 257 -
17.4 Cerebrovascular Disease, 16 min.
294
17.5 Trauma, 17.6 Demyelinating Disorders, 13 min.
17.7 Dementia and Degenerative Disorders, 35 min.
17.8 CNS Tumors, 12 min.
Obstetrics, pp. 295 -
330
13.1 Vulva, 22 min.
13.2 Vagina, 14 min.
13.3 Cervix, 20 min.
13.4 Endometrium and Myometrium, 31 min.
13.5 Ovary, 9 min.
13.6 Ovarian Tumors, 33 min.
13.7 Gestational Pathology, 24 min.
Gynecology, pp. 331
14.1 Penis, 7 min.
- 368
14.2 Testicle, 9 min.
14.3 Testicular Tumors, 13 min.
14.4 Prostate, 12 min.
16.1 Introduction, 7 min.
16.2 Inflammatory Conditions, 9 min.
16.3 Benign Tumors and Fibrocystic Changes, 15 min.
16.4 Breast Cancer, 29 min.
Pediatrics, pp. 369 -
420 pp. 421 -
Psychiatry,
446
9.1 Nasopharynx, 9.2 Larynx, 8 min.
9.3 Pulmonary Infections, 20 min.
9.4 Chronic Obstructive Pulmonary Disease, 50 min.
Pulmonary, pp. 447 - 9.5 Restrictive Diseases, 22 min.
466 9.6 Pulmonary Hypertension, 9.7 Respiratory Distress
Syndromes, 15 min.
9.8 Lung Cancer, 18 min.
9.9 Pleura, 3 min.
 12.1 Congenital, 12 min.
12.2 Acute Renal Failure (ARF), 15 min. 12.3 Nephrotic
Syndrome, 27 min.
Renal/Genitourinar 12.4 Nephritic Syndrome, 12 min.
y, pp. 467 - 492 12.5 Urinary Tract Infection, 12.6 Nephrolithiasis, 12.7
Chronic Renal Failure, 16 min.
12.8 Renal Neoplasia, 6 min.
12.9 Lower Urinary Tract Carcinoma, 7 min.
Emergency
Medicine, pp. 493 -
516
5.1 Anemia, 7 min.
5.2 Microcytic Anemias Part 1, 28 min.

5.2 Microcytic Anemias Part 2, 19 min. Hematology & Oncology

5.2 Microcytic Anemias Part 3, 19 min. Hematology & Oncology

5.3 Macrocytic Anemia, 22 min. Hematology & Oncology

5.4 Normocytic Anemia, 15 min. Hematology & Oncology

5.5 Normocytic Anemias w/ Extravascular Hemolysis, 26 min

5.6 Normocytic Anemias w/ Intravascular Hemolysis, 5.7 An

6.1 Leukopenia and Leukocytosis, 21 min. Hematology & Onco
6.2 Acute Leukemia, 19 min. Hematology & Oncology

6.3 Chronic Leukemia, 11 min. Hematology & Oncology

6.4 Myeloproliferative Disorders (MPD), 22 min. Hematology &

6.5 Lymphadenopathy (LAD), 6.6 Lymphoma, 6.7 Hodgkin L

6.8 Plasma Cell Disorders (Dyscrasias), 6.9 Langerhans Cell
ematology & Oncology

ematology & Oncology

gy & Oncology

ogy & Oncology

ar Hemolysis, 26 min. Hematology & Oncology

ar Hemolysis, 5.7 Anemia Due to Underproduction, 27 min. Hematology & Oncology

n. Hematology & Oncology
& Oncology

y & Oncology
22 min. Hematology & Oncology

oma, 6.7 Hodgkin Lymphoma (HL), 31 min. Hematology & Oncology

6.9 Langerhans Cell Histiocytosis, 15 min. Hematology & Oncology
Oncology